Atheromide
Brand names,
Atheromide
Analogs
Atheromide
Brand Names Mixture
Atheromide
Chemical_Formula
C12H15ClO3
Atheromide
RX_link
http://www.rxlist.com/cgi/generic2/clofibrate.htm
Atheromide
fda sheet
Atheromide
msds (material safety sheet)
Atheromide
Synthesis Reference
No information avaliable
Atheromide
Molecular Weight
242.698 g/mol
Atheromide
Melting Point
< 25 oC (boiling point 148-150°C at 25 mm Hg)
Atheromide
H2O Solubility
Insoluble
Atheromide
State
Liquid
Atheromide
LogP
3.58
Atheromide
Dosage Forms
Capsules (orange, oblong, soft-gelatin capsules, each containing 500 mg clofibrate)
Atheromide
Indication
For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet.
Atheromide
Pharmacology
Clofibrate is an antilipidemic agent similar to gemfibrozil. It acts to lower elevated serum lipids by reducing the very low-density lipoprotein fraction (Sf 20-400) rich in triglycerides. Serum cholesterol may be decreased, particularly in those patients whose cholesterol elevation is due to the presence of IDL as a result of Type III hyperlipoproteinemia. Several investigators have observed in their studies that clofibrate may produce a decrease in cholesterol linoleate but an increase in palmitoleate and oleate, the latter being considered atherogenic in experimental animals. The significance of this finding is unknown at this time. Reduction of triglycerides in some patients treated with clofibrate or certain of its chemically and clinically similar analogs may be associated with an increase in LDL cholesterol. Increase in LDL cholesterol has been observed in patients whose cholesterol is initially normal. Animal studies suggest that clofibrate interrupts cholesterol biosynthesis prior to mevalonate formation.
Atheromide
Absorption
Completely but slowly absorbed from the intestine. Between 95% and 99% of an oral dose of clofibrate is excreted in the urine as free and conjugated clofibric acid; thus, the absorption of clofibrate is virtually complete.
Atheromide
side effects and Toxicity
Oral, mouse: LD50 = 1220 mg/kg; Oral, rabbit: LD50 = 1370 mg/kg; Oral, rat: LD50 = 940 mg/kg. No reported case of overdosage in humans.
Atheromide
Patient Information
Atheromide
Organisms Affected
Humans and other mammals